LONDON & BURLINGAME, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication ...
(Reuters) - GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once ...
GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion today supporting the use ...
Don’t Settle for Uncontrolled Symptoms: When It’s Time to Rethink Your Approach to Asthma Management
(BPT) – This content is sponsored by GSK. Those who live with asthma know that symptoms can come on suddenly, literally taking your breath away. Even if you’re avoiding triggers and following your ...
New asthma indication for Trelegy Ellipta introduces an important option for patients to the current treatment paradigm The FDA-approved strength for both COPD and asthma is fluticasone furoate / ...
Don’t Settle for Uncontrolled Symptoms: When It’s Time to Rethink Your Approach to Asthma Management
(BPT) – This content is sponsored by GSK. Those who live with asthma know that symptoms can come on suddenly, literally taking your breath away. Even if you’re avoiding triggers and following your ...
Use with caution in patients with prostatic hyperplasia or bladder-neck obstruction and instruct patients to contact a healthcare provider immediately if symptoms occur. Use Trelegy Ellipta with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback